JPRN-jRCT1071210006已完成未知
Administration study on preparation of testosterone undecanoate to healthy adult males
Yonemura Takuma0 个研究点目标入组 8 人开始时间: 2021年4月7日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 35age old（—）
- 性别
- Male
入选标准
- •Person with BMI 18.5 or more and less than 25.0 at the time of prior examination.
- •Person who is judged by Principal investigator or Sub-investigator that there is no problem with participation in the test.
排除标准
- •1) Person who has caused allergic symptoms due to the study drug or the component of the study drug.
- •2) Person who is being treated for any disease or who may be treated during the test period.
- •3) A person suspected of having the following diseases or a person with a medical history.
- •Tumor, cancer, liver disease, kidney disease, heart disease, diabetes, blood coagulation disorder, prostatic hyperplasia, sleep Apnea
- •4) Alcohol or drug dependents, depression or those with a medical history.
- •5)Those who are confirmed negative by SARS-CoV-2 test or who are suspected of having a new coronavirus infection.
- •6) A person who used a medicinal or over-the-counter medication within 2 weeks of the scheduled administration of the study drug.
- •7) Those who have taken one or more supplements, foods containing Hyperethesia, grapefruit or their processed products within one week of the scheduled administration of the study drug.
- •8) A person who has received another investigational drug or investigational drug within 16 weeks of the scheduled study drug administration date, or an investigational drug or investigational drug containing an approved component within 12 weeks.
- •9) Patients who received blood of 200 mL or more within 30 days of the scheduled administration of the study drug and 400 mL or more within 90 days and those who received blood donation of the component within 14 days of the scheduled administration.
- •10) Person who weighs less than 50 kg at the time of pre-examination.
- •11) A person who has been judged by the Principal investigator or Sub-investigator to be inappropriate to participate in this test.
研究者
相似试验
招募中
3 期
Testosterone therapy for the treatment of nonalcoholic fatty liver diseaseNonalcoholic fatty liver diseaseACTRN12619000701123Austin Health120
已完成
4 期
Testosterone for gender dysphoria in transgender meDepressionTransgender healthGender dysphoriaSuicideMetabolic and Endocrine - Other endocrine disordersMental Health - DepressionMental Health - SuicideACTRN12621000716864niversity of Melbourne64
已完成
不适用
Examination of the usefulness of testosterone cream for Late Onset Hypogonadism syndromeOH SyndromeJPRN-UMIN000029540Chibanisi-General Hospital200
已完成
不适用
Administration study of Testosterone ester in healthy adult malesHealthy adult subjectsSample collection for evaluating analysis and sampling methods in antidopingJPRN-jRCT1071220039Yomenura Takuma7
尚未招募
不适用
An investigation of the role of testosterone, cortisol and serotonin in aggressioagressieAggressionNL-OMON37187Radboud Universiteit Nijmegen200